Patient Toolkit

Welcome to the STRIVE Patient Toolkit, a resource center for patients who have been diagnosed with Non-Hodgkin’s Lymphoma (NHL) to help them educate themselves about the disease and non-Hodgkin’s lymphoma treatment options, and become active participants while making healthcare decisions.

This NHL cancer patient toolkit provides links with information about diagnosis and non-Hodgkin’s lymphoma treatment options; advice on living with NHL including side effects, palliative care, and patient support; answers to frequently asked questions; and more.

If you have further questions about non-Hodgkin’s lymphoma treatment or general questions on NHL cancer after reading through the material, we encourage you to Talk to us!

  • This year (2022), more than 80,000 people (including children) will be diagnosed with Non-Hodgkin’s Lymphoma (NHL).1
  • This year (2022), more than 20,000 people will die of NHL.1
  • NHL is one of the more common cancers in children, teenagers, and young adults.1
  • Overall, 1 in 42 men and 1 in 52 women have a chance of being diagnosed with NHL.1
  • NHL is the seventh most prevalent cancer in the US.2
Scroll to Top

Did you come from ENCOMPASS?

Did you come from

View more tumor types at